How health systems are preparing for a potential 340B overhaul
(By: Alexandra Murphy for Becker’s Hospital Review) As federal scrutiny and legislative proposals continue around the 340B drug pricing program,
Read More
Part D/Prescription Drugs
The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters
(By Juliette Cubanski and Tricia Neuman for KFF Health News Published: Jul 16, 2025) Ahead of Medicare’s annual mid-year announcement
Read MoreKey Facts About Medicare Part D Enrollment, Premiums, and Cost Sharing in 2025
(By Juliette Cubanski and Anthony Damico for The Kaiser Family Foundation Published: Jul 16, 2025) The Medicare Part D program
Read More4 pressing drug shortages
(By: Alexandra Murphy for Becker’s Hospital Review) While the total number of drug shortages in the U.S. appears to be decreasing
Read MoreWhat is the Medicare prescription cap
Two types of Medicare plans cover your prescription drug needs: Stand-alone Medicare Part D plans or Medicare Advantage prescription drug
Read MoreThe Trump administration’s approach to PBMs, so far: 5 things to know
(By: Rylee Wilson for Becker’s Hospital Review) President Donald Trump has signed two executive orders aimed at reducing the cost
Read More194 drugs currently in shortage: FDA
(By: Alexandra Murphy for Becker’s Hospital Review) Nationwide, hospitals and pharmacies are seeing ongoing shortages of medications including some anesthetics,
Read MoreSenate bill aims to rebuild drug manufacturing infrastructure: 3 notes
(By: Alexandra Murphy for Becker’s Hospital Review) A bipartisan group of U.S. senators has reintroduced a bill designed to address
Read MoreEli Lilly tightens rules for telehealth partners
(By: Alexandra Murphy for Becker’s Hospital Review) Eli Lilly will partner only with telehealth firms that agree to stop selling
Read MoreThe next batch of drugs under negotiations
The Centers for Medicare and Medicaid Services (CMS) issued a draft guidance on May 12th for the third round of
Read More